Question
Type I and Type II errors Balancing the Risks of Errors in Hypothesis Testing The U.S. FDA is responsible for approving new drugs. Many consumer
Type I and Type II errors Balancing the Risks of Errors in Hypothesis Testing The U.S. FDA is responsible for approving new drugs. Many consumer groups feel that the approval process is too easy and, therefore, too many drugs are approved that are later found to be unsafe. On the other hand, a number of industry lobbyists have pushed for a more lenient approval process so that pharmaceutical companies can get new drugs approved more easily and quickly. This is from an article in the Wall Street Journal. Consider a null hypothesis that a new, unapproved drug is unsafe and an alternative hypothesis that a new, unapproved drug is safe. a) Explain the risks of committing a Type 1 or Type 2 error. b) Which type of error is the consumer group trying to avoid? c) Which type of error is the industry lobbyists trying to avoid? d) How would it be possible to lower the chances of both Type 1 and 2 errors? Think about the recent vaccinations developed for Covid in record time. Do you recall reading about the items above and are they important?
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started